// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "FOR LC CLO CT MHC INFORMATION alkylation reagent DTT PRIDE FDR HUPO proteomics data acquisition method SHALL mass NOT HF MAY OR WILL DISCLAIMS MS:1001251 PRM INITIATIVE MS TA ZFA EFO PEPTIDESEQ URI INCLUDING disease stage IS SH characteristics developmental stage REQUIRED LIMITED EW PATCH RFC DOID CF MINOR SP UBERON MOD RECOMMENDED MERCHANTABILITY FITNESS fractionation method IAA PATO RECOMMEND USE COLUMN disease XML label sex depletion BMC ALL CID SN BTO MONDO THAT AC REQUIRES III IMPLIED OF ISA instrument reduction reagent age collision energy NCE spiked compound CN EM SHOULD OPTIONAL VK CL CPTAC MT NT CV technical replicate ancestry category exclamation MIAME THE ID COULD CELL PO source name SDRF STANDARDS pooled sample LI HTML HCD URL ... BE DDA PMID PSI organism WARRANTY data file file your TO TAB PMCID PS PTM ENVO CS fraction identifier VCF biological replicate HANCESTRO NCBI dissociation method TIP HEREIN MAJOR INFRINGE AS RIGHTS SILAC PP DJ individual sample ANY EBI MUST XL RAW PRIDE:0000659 BRENDA NOTE TMT PROTEOMICS JA replicate EXPRESS IDF PURPOSE BUT cleavage agent details source name_ and _assay name SWATH DIA II README MAGE IMPORTANT ROW cell type biosample accession number QY WARRANTIES PARTICULAR SRM organism part MC"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "FOR LC CLO CT MHC INFORMATION alkylation reagent DTT PRIDE FDR HUPO proteomics data acquisition method SHALL mass NOT HF MAY OR WILL DISCLAIMS MS:1001251 PRM INITIATIVE MS TA ZFA EFO PEPTIDESEQ URI INCLUDING disease stage IS SH REQUIRED LIMITED EW PATCH RFC DOID CF MINOR SP UBERON MOD RECOMMENDED MERCHANTABILITY FITNESS fractionation method IAA PATO RECOMMEND USE COLUMN disease label sex depletion BMC ALL CID SN BTO MONDO THAT AC REQUIRES III IMPLIED OF ISA instrument reduction reagent age collision energy NCE spiked compound CN EM SHOULD OPTIONAL VK CL CPTAC MT NT CV technical replicate ancestry category MIAME THE COULD CELL PO SDRF STANDARDS pooled sample LI HTML HCD URL ... BE DDA PMID PSI organism WARRANTY data file TO TAB PMCID PS PTM ENVO CS fraction identifier VCF biological replicate HANCESTRO NCBI dissociation method HEREIN MAJOR INFRINGE AS RIGHTS SILAC PP DJ individual ANY EBI MUST XL RAW PRIDE:0000659 BRENDA TMT PROTEOMICS JA EXPRESS IDF PURPOSE BUT cleavage agent details SWATH DIA II README MAGE ROW cell type biosample accession number QY WARRANTIES PARTICULAR SRM organism part MC"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000623 CL:0000788 CL:0000913 CL:0000576 CL:0000236 MAY UBERON:0001359 CL:0000066 NK CL:0000451 UBERON:0001977 UBERON:0000955 EFO synthetic peptide developmental stage MONDO:0005148 disease model PDX DOID UBERON MONDO:0005105 UBERON:0001969 PATO CML APP CL:0000787 UBERON:0001155 disease CL:0000057 CL:0000625 sex depletion UBERON:0001088 ALL PATO:0000384 MONDO:0005138 MONDO DSS age CSF COVID xenograft SHOULD CL UBERON:0002048 MONDO:0100096 MONDO:0005575 UBERON:0002113 MONDO:0005180 ancestry category exclamation ID CL:0000898 source name PO SDRF UBERON:0000310 CL:0000235 CL:0000233 MONDO:0008383 URL lib UBERON:0002097 organism PTM PATO:0000383 enrichment process biological replicate HANCESTRO NCBI CL:0000084 TIP CL:0000624 CL:0000540 MONDO:0004946 CL:0000813 individual CL:0000815 PATO:0000461 MUST MONDO:0004975 compound NOTE UBERON:0000948 NSG UBERON:0002107 MONDO:0005301 CL:0000232 IMPORTANT cell type CL:0000182 PATO:0001340 organism part UBERON:0000178 MONDO:0004989"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000623 CL:0000788 CL:0000913 CL:0000576 CL:0000236 MAY UBERON:0001359 CL:0000066 NK CL:0000451 UBERON:0001977 UBERON:0000955 EFO synthetic peptide developmental stage MONDO:0005148 disease model PDX DOID UBERON MONDO:0005105 UBERON:0001969 PATO CML APP CL:0000787 UBERON:0001155 disease CL:0000057 CL:0000625 sex depletion UBERON:0001088 ALL PATO:0000384 MONDO:0005138 MONDO DSS age CSF COVID xenograft SHOULD CL UBERON:0002048 MONDO:0100096 MONDO:0005575 UBERON:0002113 MONDO:0005180 ancestry category ID CL:0000898 source name PO SDRF UBERON:0000310 CL:0000235 CL:0000233 MONDO:0008383 URL UBERON:0002097 organism PTM PATO:0000383 enrichment process biological replicate HANCESTRO NCBI CL:0000084 CL:0000624 CL:0000540 MONDO:0004946 CL:0000813 individual CL:0000815 PATO:0000461 MUST MONDO:0004975 compound UBERON:0000948 NSG UBERON:0002107 MONDO:0005301 CL:0000232 cell type CL:0000182 PATO:0001340 organism part UBERON:0000178 MONDO:0004989"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C71732 NCIT:C15632 ER dose AJCC breast cancer subtype IV MONDO:0004995 NCIT:C18058 NCIT:C65107 NCIT:C53556 PR NCIT:C4870 NCIT:C18213 smoking status HANCESTRO:0006 NCIT:C18206 NCIT:C14168 gestational age body mass index EFO NCIT:C28079 NCIT:C53554 NCIT:C15313 UO sampling time point MONDO:0002050 disease stage tumor grade pre-existing condition MONDO:0005148 NCIT:C28054 NCIT:C14167 NCIT:C14169 TNM NCIT:C81328 disease NCIT:C53553 NCIT:C68804 NCI BMI NCIT:C27970 height sex CHEBI:28748 MONDO III age GDPR treatment NCIT:C27966 Ann Arbor stage NCIT:C14174 prior treatment treatment status ethnicity ancestry category exclamation ID PD NCIT:C28078 SDRF secondary condition HANCESTRO:0009 MONDO:0005300 NCIT:C15445 organism NCIT NCIT:C27971 MONDO:0005044 medication history treatment response diet Dukes stage HANCESTRO:0005 HANCESTRO time post treatment CHEBI:41774 NCIT:C62723 menopausal status ACE pregnancy status weight PREFERRED alcohol consumption NCIT:C65106 NCIT:C15262 individual MONDO:0011122 NCIT:C65108 TNM staging compound NOTE NCIT:C28076 CHEBI:27899 HIPAA NCIT:C16358 NCIT:C81327 CHEBI:6801 II MONDO:0004979 NCIT:C28077 IMPORTANT NCIT:C15329 organism part HANCESTRO:0010 NCIT:C53555"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C71732 NCIT:C15632 ER dose AJCC breast cancer subtype IV MONDO:0004995 NCIT:C18058 NCIT:C65107 NCIT:C53556 PR NCIT:C4870 NCIT:C18213 smoking status HANCESTRO:0006 NCIT:C18206 NCIT:C14168 gestational age body mass index EFO NCIT:C28079 NCIT:C53554 NCIT:C15313 UO sampling time point MONDO:0002050 disease stage tumor grade pre-existing condition MONDO:0005148 NCIT:C28054 NCIT:C14167 NCIT:C14169 TNM NCIT:C81328 disease NCIT:C53553 NCIT:C68804 NCI BMI NCIT:C27970 height sex CHEBI:28748 MONDO III age GDPR treatment NCIT:C27966 Ann Arbor stage NCIT:C14174 prior treatment treatment status ethnicity ancestry category ID PD NCIT:C28078 SDRF secondary condition HANCESTRO:0009 MONDO:0005300 NCIT:C15445 organism NCIT NCIT:C27971 MONDO:0005044 medication history treatment response diet Dukes stage HANCESTRO:0005 HANCESTRO time post treatment CHEBI:41774 NCIT:C62723 menopausal status ACE pregnancy status weight PREFERRED alcohol consumption NCIT:C65106 NCIT:C15262 individual MONDO:0011122 NCIT:C65108 TNM staging compound NCIT:C28076 CHEBI:27899 HIPAA NCIT:C16358 NCIT:C81327 CHEBI:6801 II MONDO:0004979 NCIT:C28077 NCIT:C15329 organism part HANCESTRO:0010 NCIT:C53555"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "REQUIRED modification parameters UNIMOD:21 MS:1001309 CS fraction identifier proteomexchange accession number CF file uri PRIDE SHOULD MOD MS:1001917 TIP RECOMMENDED MSD SILAC MT NT KR UNIMOD:1 UNIMOD:737 PP proteomics data acquisition method MS2 analyzer type scan window lower limit sample fraction technical replicate ELISA MUST MGF XL TS SCIEX fragment mass tolerance RAW HF MM exclamation ID UNIMOD:4 TMT NOTE SDRF ST MS:1001251 MS:1001313 RPPA cleavage agent details PRM MS:1001303 MS1 scan range PRIDE:0000663 LTQ MS DIA UNIMOD:35 FTP URL label IMPORTANT TA DDA precursor mass tolerance PSI scan window upper limit data file URI MRM UNIMOD MS:1001306 AC SRM TOF instrument"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "REQUIRED modification parameters UNIMOD:21 MS:1001309 CS fraction identifier proteomexchange accession number CF file uri PRIDE SHOULD MOD MS:1001917 RECOMMENDED MSD SILAC MT NT KR UNIMOD:1 UNIMOD:737 PP proteomics data acquisition method MS2 analyzer type scan window lower limit technical replicate ELISA MUST MGF XL TS SCIEX fragment mass tolerance RAW HF MM ID UNIMOD:4 TMT SDRF ST MS:1001251 MS:1001313 RPPA cleavage agent details PRM MS:1001303 MS1 scan range PRIDE:0000663 LTQ MS DIA UNIMOD:35 FTP URL label TA DDA precursor mass tolerance PSI scan window upper limit data file URI MRM UNIMOD MS:1001306 AC SRM TOF instrument"
  }
];
